Surgery plus deferoxamine for brain bleeds
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests a combination of a minimally invasive surgery to remove the brain bleed and a medication called deferoxamine (which may help reduce damage from the bleed). The goal is to see if this combination helps improve recovery after a brain hemorrhage.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 80 years old.
- You must have had a brain bleed (intracerebral hemorrhage) confirmed by a CT scan, and the bleeding must have started within the last 24 hours.
- You must have some neurologic symptoms (measured by a stroke severity score of 6 or more).
- You must have been able to do your usual daily activities without help before the brain bleed.
- You must not be taking certain blood thinners (like apixaban, rivaroxaban, dabigatran, or Coumadin) at the time of the bleeding.
- You must not have serious heart, kidney, or lung disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two medicines (deferoxamine and colchicine) to see if they can prevent further brain damage after a spontaneous brain bleed (intracerebral hemorrhage). The goal is to improve recovery by reducing inflammation and iron-related damage.
This trial looks at how people recover after surgery for a brain bleed (intracerebral hemorrhage). It aims to find the best timing for treatment to improve recovery. If you have had a brain bleed and are eligible for surgery, you may be able to join.
This study tests whether a minimally invasive surgery can safely remove a deep brain bleed (intracerebral hemorrhage) to improve recovery. It aims to see if this gentler approach helps people with moderate-sized bleeds do better than standard care.
This trial tests a less invasive surgery to remove small blood clots (20–30 ml) in the basal ganglia, a deep part of the brain. It may help people who are awake but have a reduced level of consciousness after a recent brain bleed.
This study tracks patients who have had sudden, severe bleeding in the brain and received minimally invasive surgery (a less-invasive surgical approach) to treat it. Researchers want to understand outcomes and improve treatment for this serious condition.
This trial looks at whether starting brain surgery within 8 hours after a type of stroke called intracerebral hemorrhage (bleeding in the brain) can improve outcomes. It’s for adults with a certain amount and location of bleeding and without common causes like an aneurysm or malformation.
Hear when a new Intracerebral Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.